Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1998 1
2000 2
2001 1
2008 1
2009 1
2012 1
2015 3
2016 2
2017 1
2018 1
2019 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.
Vadillo E, Dorantes-Acosta E, Pelayo R, Schnoor M. Vadillo E, et al. Blood Rev. 2018 Jan;32(1):36-51. doi: 10.1016/j.blre.2017.08.006. Epub 2017 Aug 15. Blood Rev. 2018. PMID: 28830639 Review.
T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% and 25% of total childhood and adult ALL cases, respectively. ...Here, we summarize current knowledge about molecular mechanisms of leukemic T-cell infiltration wi
T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% and 25% of total childhood and adult
How I Diagnose Acute Leukemia of Ambiguous Lineage.
Weinberg OK, Arber DA. Weinberg OK, et al. Am J Clin Pathol. 2022 Jul 1;158(1):27-34. doi: 10.1093/ajcp/aqac070. Am J Clin Pathol. 2022. PMID: 35775438 Review.
The different treatment regimens for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) make ALAL a challenge both diagnostically and therapeutically. ...RESULTS: Genomic and expression profile data for MPAL reveal mutations com …
The different treatment regimens for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) …
Early lymphoid development and microenvironmental cues in B-cell acute lymphoblastic leukemia.
Purizaca J, Meza I, Pelayo R. Purizaca J, et al. Arch Med Res. 2012 Feb;43(2):89-101. doi: 10.1016/j.arcmed.2012.03.005. Epub 2012 Apr 3. Arch Med Res. 2012. PMID: 22480783 Review.
B-cell acute lymphoblastic leukemia (B-ALL) is a hematological disorder characterized by malignant and uncontrolled proliferation of B-lymphoid precursor cells in bone marrow. ...In this review we focus on the structure of the early lymphoid sys …
B-cell acute lymphoblastic leukemia (B-ALL) is a hematological disorder characterized by malignant and uncontrol …
Epigenetics in T-cell acute lymphoblastic leukemia.
Peirs S, Van der Meulen J, Van de Walle I, Taghon T, Speleman F, Poppe B, Van Vlierberghe P. Peirs S, et al. Immunol Rev. 2015 Jan;263(1):50-67. doi: 10.1111/imr.12237. Immunol Rev. 2015. PMID: 25510271 Review.
Normal T-cell development is a strictly regulated process in which hematopoietic progenitor cells migrate from the bone marrow to the thymus and differentiate from early T-cell progenitors toward mature and functional T cells. Duri …
Normal T-cell development is a strictly regulated process in which hematopoietic progenitor cells migrate from the bone …
Advances in the Genetics and Therapy of Acute Lymphoblastic Leukemia.
Chiaretti S, Gianfelici V, O'Brien SM, Mullighan CG. Chiaretti S, et al. Am Soc Clin Oncol Educ Book. 2016;35:e314-22. doi: 10.1200/EDBK_156628. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249738 Free article. Review.
Acute lymphoblastic leukemia (ALL) remains an important cause of morbidity in children and adults. ...The integration of cytogenetics, molecular biology, and immunophenotype analyses has led to the identification of defined T-ALL subgroups, such as
Acute lymphoblastic leukemia (ALL) remains an important cause of morbidity in children and adults. ...The integration o
Desperately seeking a home marrow niche for T-cell acute lymphoblastic leukaemia.
Calvo J, Fahy L, Uzan B, Pflumio F. Calvo J, et al. Adv Biol Regul. 2019 Dec;74:100640. doi: 10.1016/j.jbior.2019.100640. Epub 2019 Jul 27. Adv Biol Regul. 2019. PMID: 31378700 Review.
T-cell acute leukemia is a hematologic malignancy that results from the progressive acquisition of genomic abnormalities in T-cell progenitors/precursors. ...The journey of T-ALL from its arising to full blown expansion meets diffe
T-cell acute leukemia is a hematologic malignancy that results from the progressive acquisition of genomic abnor
Notch Signaling in the Bone Marrow Lymphopoietic Niche.
Sottoriva K, Pajcini KV. Sottoriva K, et al. Front Immunol. 2021 Jul 28;12:723055. doi: 10.3389/fimmu.2021.723055. eCollection 2021. Front Immunol. 2021. PMID: 34394130 Free PMC article. Review.
We will discuss how new genetic model systems indicate a pre-thymic, BM-specific role for Notch activation in early T cell development and what this means to the paradigm of lymphoid lineage commitment. Lastly, we will examine how leukemic T-cell
We will discuss how new genetic model systems indicate a pre-thymic, BM-specific role for Notch activation in early T cell
Blinatumomab for the treatment of acute lymphoblastic leukemia.
Kaplan JB, Grischenko M, Giles FJ. Kaplan JB, et al. Invest New Drugs. 2015 Dec;33(6):1271-9. doi: 10.1007/s10637-015-0289-4. Epub 2015 Sep 17. Invest New Drugs. 2015. PMID: 26383529 Review.
BACKGROUND: Acute lymphoblastic leukemia (ALL) is a potentially fatal disease that involves clonal expansion of early lymphoid progenitor cells. Much of drug development for ALL treatment involves targeting antigens of the clonal cell sur …
BACKGROUND: Acute lymphoblastic leukemia (ALL) is a potentially fatal disease that involves clonal expansion of earl
Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.
Yamamoto K, Kawamoto S, Mizutani Y, Yakushijin K, Yamashita T, Nakamachi Y, Kawano S, Hayashi Y, Matsuoka H, Minami H. Yamamoto K, et al. Cytogenet Genome Res. 2016;149(3):165-170. doi: 10.1159/000448447. Epub 2016 Sep 9. Cytogenet Genome Res. 2016. PMID: 27607436 Review.
The t(12;17)(p13;q1121) translocation is a very rare but recurrent cytogenetic aberration observed predominantly in early pre-B acute lymphoblastic leukemia (ALL) with CD19+CD10-CD33+ phenotype. ...The TAF15-ZNF384 fusion may occur in early
The t(12;17)(p13;q1121) translocation is a very rare but recurrent cytogenetic aberration observed predominantly in early pre- …
Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.
Somasundaram R, Prasad MA, Ungerbäck J, Sigvardsson M. Somasundaram R, et al. Blood. 2015 Jul 9;126(2):144-52. doi: 10.1182/blood-2014-12-575688. Epub 2015 May 19. Blood. 2015. PMID: 25990863 Free PMC article. Review.
B-lymphocyte development in the bone marrow is controlled by the coordinated action of transcription factors creating regulatory networks ensuring activation of the B-lymphoid program and silencing of alternative cell fates. This process is tightly connected to malignant t …
B-lymphocyte development in the bone marrow is controlled by the coordinated action of transcription factors creating regulatory networks en …
20 results